In tumor immunotherapy, the upregulation of NKG2D ligands on tumor cells helps enhance NK cell infiltration and promote cytotoxicity against cancer cells [19], thereby playing an important role in the immune surveillance and clearance of tumor cells. Here, KLRK1 is linked to cancer.